Team:Paris/Transduction testing
From 2009.igem.org
(→Fusion) |
(→Fusion) |
||
(18 intermediate revisions not shown) | |||
Line 116: | Line 116: | ||
AidA and Linker : Design, synthesize and order in two parts due to the seize. | AidA and Linker : Design, synthesize and order in two parts due to the seize. | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
+ | |||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 125: | Line 126: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 141: | Line 135: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | + | |bgcolor="#BCCDFD"|- | |
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
Line 170: | Line 158: | ||
|bgcolor="#CBD1FD"|'''Digestion:''' | |bgcolor="#CBD1FD"|'''Digestion:''' | ||
- | |bgcolor="#BCCDFD"| | + | none |
+ | |bgcolor="#BCCDFD"|- | ||
+ | |||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
- | |bgcolor="#F8F8F8"|''' | + | |bgcolor="#F8F8F8"|'''Digestion checking:''' |
ok | ok | ||
- | |bgcolor="#E0E3FE"|''' | + | |bgcolor="#E0E3FE"|'''Digestion checking:''' |
+ | ok | ||
- | |||
- | |bgcolor="#CBD1FD"|''' | + | |bgcolor="#CBD1FD"|'''Digestion checking:''' |
+ | none | ||
- | + | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | - | ||
Line 200: | Line 191: | ||
|bgcolor="#CBD1FD"|'''Ligation:''' | |bgcolor="#CBD1FD"|'''Ligation:''' | ||
- | |bgcolor="#BCCDFD"| | + | none |
+ | |bgcolor="#BCCDFD"|- | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 212: | Line 204: | ||
|bgcolor="#CBD1FD"|'''Colony PCR :''' | |bgcolor="#CBD1FD"|'''Colony PCR :''' | ||
+ | none | ||
- | + | |bgcolor="#BCCDFD"|- | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | + | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 228: | Line 218: | ||
|bgcolor="#CBD1FD"|'''Miniprep:''' | |bgcolor="#CBD1FD"|'''Miniprep:''' | ||
+ | none | ||
- | + | |bgcolor="#BCCDFD"|- | |
- | + | ||
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | + | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''Sequencing :''' | |bgcolor="#F8F8F8"|'''Sequencing :''' | ||
- | |||
unecessary | unecessary | ||
|bgcolor="#E0E3FE"|'''Sequencing :''' | |bgcolor="#E0E3FE"|'''Sequencing :''' | ||
- | + | none | |
- | + | ||
|bgcolor="#CBD1FD"|'''Sequencing :''' | |bgcolor="#CBD1FD"|'''Sequencing :''' | ||
+ | none | ||
- | |||
- | |||
- | + | |bgcolor="#BCCDFD"|- | |
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 261: | Line 245: | ||
|bgcolor="#CBD1FD"|'''Stock glycerol''' | |bgcolor="#CBD1FD"|'''Stock glycerol''' | ||
- | + | none | |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
- | |||
|} | |} | ||
Line 292: | Line 275: | ||
|width="300px" ; bgcolor="#CBD1FD"| Column 3 | |width="300px" ; bgcolor="#CBD1FD"| Column 3 | ||
|width="300px" ; bgcolor="#BCCDFD"| Column 4 | |width="300px" ; bgcolor="#BCCDFD"| Column 4 | ||
- | |||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 305: | Line 287: | ||
Fos : previously done | Fos : previously done | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
+ | |||
- | |||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 316: | Line 298: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | + | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 332: | Line 312: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
Line 357: | Line 337: | ||
|bgcolor="#E0E3FE"|'''Digestion:''' | |bgcolor="#E0E3FE"|'''Digestion:''' | ||
- | |bgcolor="#CBD1FD"| | + | none |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#CBD1FD"|- |
+ | |bgcolor="#BCCDFD"|- | ||
- | |||
- | |||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
- | |bgcolor="#F8F8F8"|''' | + | |bgcolor="#F8F8F8"|'''Digestion checking:''' |
ok | ok | ||
- | |bgcolor="#E0E3FE"|''' | + | |bgcolor="#E0E3FE"|'''Digestion checking:''' |
- | + | none | |
- | + | ||
- | + | ||
+ | |bgcolor="#CBD1FD"| | ||
+ | - | ||
+ | |bgcolor="#BCCDFD"| | ||
- | - | ||
- | |||
- | |||
- | |||
- | |||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 389: | Line 365: | ||
|bgcolor="#E0E3FE"|'''Ligation:''' | |bgcolor="#E0E3FE"|'''Ligation:''' | ||
- | |bgcolor="#CBD1FD"| | + | none |
- | |bgcolor="#BCCDFD"|' | + | |bgcolor="#CBD1FD"|- |
+ | |bgcolor="#BCCDFD"|'- | ||
+ | |||
- | |||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 399: | Line 376: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"|'''Colony PCR :''' | + | |bgcolor="#E0E3FE"|'''Colony PCR:''' |
+ | none | ||
- | + | |bgcolor="#CBD1FD"|- | |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | - | ||
Line 416: | Line 391: | ||
|bgcolor="#E0E3FE"|'''Miniprep:''' | |bgcolor="#E0E3FE"|'''Miniprep:''' | ||
- | + | none | |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | + | |bgcolor="#BCCDFD"|- | |
- | - | + | |
- | + | ||
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | + | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''Sequencing :''' | |bgcolor="#F8F8F8"|'''Sequencing :''' | ||
- | - | + | -ok |
|bgcolor="#E0E3FE"|'''Sequencing :''' | |bgcolor="#E0E3FE"|'''Sequencing :''' | ||
- | - | + | -none |
- | |bgcolor="#CBD1FD"|' | + | |bgcolor="#CBD1FD"|'- |
- | + | |bgcolor="#BCCDFD"|- | |
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
|bgcolor="#F8F8F8"| '''Stock glycerol:''' | |bgcolor="#F8F8F8"| '''Stock glycerol:''' | ||
+ | none | ||
unecessary | unecessary | ||
|bgcolor="#E0E3FE"|'''Stock glycerol''' | |bgcolor="#E0E3FE"|'''Stock glycerol''' | ||
- | + | none | |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | + | |bgcolor="#BCCDFD"|- | |
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | - | ||
Line 515: | Line 480: | ||
{| | {| | ||
- | |- style="background: #0a3585; text-align: center; color:black; font-weight:bold; " | + | |- style="background: #0a3585; text-align: center; color:black; font-weight:bold;font-size:14px " |
|width="300px" ; bgcolor="#F8F8F8"| Column 1 | |width="300px" ; bgcolor="#F8F8F8"| Column 1 | ||
|width="300px" ; bgcolor="#E0E3FE"| Column 2 | |width="300px" ; bgcolor="#E0E3FE"| Column 2 | ||
|width="300px" ; bgcolor="#CBD1FD"| Column 3 | |width="300px" ; bgcolor="#CBD1FD"| Column 3 | ||
|width="300px" ; bgcolor="#BCCDFD"| Column 4 | |width="300px" ; bgcolor="#BCCDFD"| Column 4 | ||
- | |||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 543: | Line 507: | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
- | + | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''Verification on gel :''' | |bgcolor="#F8F8F8"|'''Verification on gel :''' | ||
Line 552: | Line 515: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 568: | Line 524: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
Line 588: | Line 537: | ||
mRFP E/S | mRFP E/S | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| - |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| - |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| - |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
- | |bgcolor="#F8F8F8"|''' | + | |bgcolor="#F8F8F8"|'''Digestion checking:''' |
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
Line 614: | Line 556: | ||
mRFP E/S Ter E/X in Ter vector | mRFP E/S Ter E/X in Ter vector | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| - |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 623: | Line 565: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 639: | Line 574: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | + | ||
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''Sequencing :''' | |bgcolor="#F8F8F8"|'''Sequencing :''' | ||
+ | ok | ||
+ | |bgcolor="#E0E3FE"| | ||
- | - | ||
- | |bgcolor="# | + | |bgcolor="#CBD1FD"| |
- | + | ||
- | - | ||
- | + | |bgcolor="#BCCDFD"| | |
- | + | ||
- | + | ||
- | + | ||
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 670: | Line 593: | ||
- | - | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | + | |bgcolor="#CBD1FD"|- | |
- | - | + | |bgcolor="#BCCDFD"|- |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | + | ||
- | - | + | |
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | + | |
|} | |} | ||
Line 703: | Line 619: | ||
{| | {| | ||
- | |- style="background: #0a3585; text-align: center; color:black; font-weight:bold; " | + | |- style="background: #0a3585; text-align: center; color:black; font-weight:bold;font-size:14px " |
|width="300px" ; bgcolor="#F8F8F8"| Column 1 | |width="300px" ; bgcolor="#F8F8F8"| Column 1 | ||
|width="300px" ; bgcolor="#E0E3FE"| Column 2 | |width="300px" ; bgcolor="#E0E3FE"| Column 2 | ||
|width="300px" ; bgcolor="#CBD1FD"| Column 3 | |width="300px" ; bgcolor="#CBD1FD"| Column 3 | ||
|width="300px" ; bgcolor="#BCCDFD"| Column 4 | |width="300px" ; bgcolor="#BCCDFD"| Column 4 | ||
- | |||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 731: | Line 646: | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 740: | Line 655: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | + | ||
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | + | ||
- | - | ||
Line 756: | Line 669: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | - | ||
Line 776: | Line 689: | ||
mRFP E/S | mRFP E/S | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 785: | Line 698: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | + | ||
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | - | ||
Line 802: | Line 714: | ||
mRFP E/S Ter E/X in Ter vector | mRFP E/S Ter E/X in Ter vector | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| - |
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
Line 811: | Line 723: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | - | ||
Line 827: | Line 739: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | + | ||
- | - | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''Sequencing :''' | |bgcolor="#F8F8F8"|'''Sequencing :''' | ||
+ | ok | ||
- | + | |bgcolor="#E0E3FE"| | |
- | + | ||
- | |bgcolor="#E0E3FE"| | + | |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | + | ||
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | + | ||
- | - | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 858: | Line 766: | ||
- | - | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | + | ||
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | - | ||
Line 890: | Line 797: | ||
{| | {| | ||
- | |- style="background: #0a3585; text-align: center; color:black; font-weight:bold; " | + | |- style="background: #0a3585; text-align: center; color:black; font-weight:bold;font-size:14px " |
- | |width="300px" ; bgcolor="#F8F8F8"| | + | |width="300px" ; bgcolor="#F8F8F8"| Column 1 |
- | |width="300px" ; bgcolor="#E0E3FE"| | + | |width="300px" ; bgcolor="#E0E3FE"| Column 2 |
- | |width="300px" ; bgcolor="#CBD1FD"| | + | |width="300px" ; bgcolor="#CBD1FD"| Column 3 |
- | |width="300px" ; bgcolor="#BCCDFD"| | + | |width="300px" ; bgcolor="#BCCDFD"| Column 4 |
- | + | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''PCR :''' | |bgcolor="#F8F8F8"|'''PCR :''' | ||
- | + | FecA matrix: K12 | |
- | |bgcolor="#E0E3FE"|' | + | pBAD: |
- | |bgcolor="#CBD1FD"| | + | |
- | |bgcolor="#BCCDFD"| | + | OmpAs: pINR2 |
+ | |||
+ | |bgcolor="#E0E3FE"|'- | ||
+ | |bgcolor="#CBD1FD"|- | ||
+ | |bgcolor="#BCCDFD"|- | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
Line 911: | Line 821: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"| |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
- | - | ||
Line 927: | Line 837: | ||
ok | ok | ||
- | |bgcolor="#E0E3FE"| | + | |bgcolor="#E0E3FE"|- |
- | - | ||
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"|- |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"|- |
- | - | ||
Line 943: | Line 853: | ||
|bgcolor="#F8F8F8"|'''Digestion:''' | |bgcolor="#F8F8F8"|'''Digestion:''' | ||
- | + | pBAD E/S | |
|bgcolor="#E0E3FE"|'''Digestion:''' | |bgcolor="#E0E3FE"|'''Digestion:''' | ||
- | |bgcolor="#CBD1FD"| | + | none |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#CBD1FD"|- |
+ | |bgcolor="#BCCDFD"|- | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
- | |bgcolor="#F8F8F8"|''' | + | |bgcolor="#F8F8F8"|'''Digestion checking''' |
ok | ok | ||
- | |bgcolor="#E0E3FE"|''' | + | |bgcolor="#E0E3FE"|'''Digestion checking''' |
- | + | none | |
- | |bgcolor="#CBD1FD"| | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | + | ||
- | - | ||
Line 969: | Line 879: | ||
|bgcolor="#F8F8F8"|'''Ligation:''' | |bgcolor="#F8F8F8"|'''Ligation:''' | ||
- | + | none | |
- | |bgcolor="#E0E3FE"|'''Ligation:''' | + | |bgcolor="#E0E3FE"|'''Ligation:''' |
- | |bgcolor="#CBD1FD"| | + | none |
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#CBD1FD"|- |
+ | |bgcolor="#BCCDFD"|- | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
|bgcolor="#F8F8F8"|'''Colony PCR :''' | |bgcolor="#F8F8F8"|'''Colony PCR :''' | ||
- | + | none | |
|bgcolor="#E0E3FE"|'''Colony PCR :''' | |bgcolor="#E0E3FE"|'''Colony PCR :''' | ||
+ | none | ||
- | + | |bgcolor="#CBD1FD"| | |
- | + | ||
- | |bgcolor="#CBD1FD"| | + | |
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | + | ||
- | - | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
- | |bgcolor="#F8F8F8"|'''Miniprep | + | |bgcolor="#F8F8F8"|'''Miniprep''' |
- | + | none | |
- | |bgcolor="#E0E3FE"|'''Miniprep | + | |bgcolor="#E0E3FE"|'''Miniprep''' |
- | + | none | |
- | + | ||
- | + | ||
+ | |bgcolor="#CBD1FD"| | ||
- | - | ||
- | |bgcolor="#BCCDFD"| | + | |bgcolor="#BCCDFD"| |
- | - | ||
|- style="background: #bebebe; text-align: center;" | |- style="background: #bebebe; text-align: center;" | ||
- | |bgcolor="#F8F8F8"|''' | + | |bgcolor="#F8F8F8"|'''Sequencing''' |
+ | none | ||
- | + | |bgcolor="#E0E3FE"|'''Sequencing''' | |
+ | none | ||
- | |bgcolor="# | + | |bgcolor="#CBD1FD"| |
- | - | ||
- | + | |bgcolor="#BCCDFD"| | |
- | + | ||
- | + | ||
- | + | ||
- | |bgcolor="#BCCDFD"| | + | |
- | + | ||
- | - | ||
|- style="background: #d8d8d8; text-align: center;" | |- style="background: #d8d8d8; text-align: center;" | ||
|bgcolor="#F8F8F8"| '''Stock glycerol:''' | |bgcolor="#F8F8F8"| '''Stock glycerol:''' | ||
+ | none | ||
- | + | |bgcolor="#E0E3FE"| '''Stock glycerol:''' | |
- | |bgcolor="#E0E3FE"|'''Stock glycerol''' | + | none |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | |bgcolor="#CBD1FD"|- | ||
+ | |bgcolor="#BCCDFD"| | ||
- | - | ||
|} | |} |
Latest revision as of 03:38, 22 October 2009
iGEM > Paris > WetLab > Reception
Contents |
WetLab - Reception
In this section we have two kinds of experiments :
- Fusion : the construction required for the fusion of the vesicles that contain the message with the receiver.
- Transduction : the construction of the system that will be able de decypher the message.
The first part deals with G3P , OmpAL , Jun, Fos , and AIDA protein. the second with the transduction system of the fec operon (FecA, FecR, FecI).
Fusion
Fusion : the construction required for the fusion of the vesicles that contain the message.
G3P , OmpAL , Jun, Fos , and AIDA protein.
Experiments ran :
Column 1 | Column 2 | Column 3 | Column 4 |
PCR :
AidA and Linker : Design, synthesize and order in two parts due to the seize. | - | - | -
|
Verification on gel :
ok | - | - | - |
Purification on gel :
ok | - | - | -
|
Digestion:
AidA CTerm Kpn1/HindIII AidA NTerm Kpn1/HindIII | Digestion:
AidA complete E/P PSB1A3 E/P We did it to obtain a biobrick first | Digestion:
none | -
|
Digestion checking:
ok | Digestion checking:
ok
| Digestion checking:
none
|
-
|
Ligation:
AidA CTerm (Kpn1/HindIII):: aidA NTerm (Kpn1/HindIII)
| Ligation:
AidA complete E/P :: PSB1A3 E/P | Ligation:
none | - |
Colony pCR :
ok | Colony PCR:
ok | Colony PCR :
none | - |
Miniprep:
done | Miniprep:
done | Miniprep:
none | - |
Sequencing :
unecessary | Sequencing :
none | Sequencing :
none
| - |
Stock glycerol:
- | Stock glycerol
S75 | Stock glycerol
none | - |
Experiments ran :
Column 1 | Column 2 | Column 3 | Column 4 |
PCR :
Jun *: design and order to be a a mutant incapable to form homodimere. pLac : previously done SSOmpA : previously done Fos : previously done | - | - | -
|
Verification on gel :
ok |
- |
- | - |
Purification on gel :
ok |
- |
- |
|
Digestion:
pLac E/X ssOmpA E/S Jun E/X and E/P PSB1A3 E/P | Digestion:
none | - | -
|
Digestion checking:
ok | Digestion checking:
none |
- |
- |
Ligation:
pLac on PSB2K3 E/X :: ssOmpA E/S Jun E/P :: PSB1A3 E/P | Ligation:
none | - | '-
|
Colony PCR:
ok | Colony PCR:
none | -
- | -
- |
Miniprep:
ok | Miniprep:
none | - | - |
Sequencing :
-ok | Sequencing :
-none | '- | - |
Stock glycerol:
none unecessary | Stock glycerol
none | - | -
- |
G3P
Even though it has not been realized, we planned to do these experiments to verify that G3P is expressed into the bacterial surface and induces the membranal fusion.
- Surface expression of G3P
Surface expression of G3P could be seen with antibodies.
Culture of bacteria expressing OmpA-linker-G3P construction on a membrane. Adding antibodies anti-G3P. Revelation should shows whether G3P is expressed at the surface of bacteria.
- Floculation test
"Fusion" could be approached by a flocculation test.
Two separate bacterial population growth on media. A population (F-) expressing the OmpA-linker_G3P construction and a population (F +) which express sexual pilus (by expression of the episome F).
Then we growth bacteria without agitation and we look (compared to culture controls) the speed of sedimentation. Faster sedimentation is due to an interaction between bacterial populations showing an increase of contact time. At vesicle level, it induce membrane fusion.
Transduction
Transduction : the construction of the system that will be able de decypher the message.
The transduction system of the fec operon (FecA, FecR, FecI).
Experiments ran :
Column 1 | Column 2 | Column 3 | Column 4 |
PCR :
pFec matrix: K12 DNA Oligo: TM FecI matrix: K12 DNA Oligo: TM FecR 1-85 matrix: K12 DNA Oligo: TM mRFP matrix: PSB1A3 (previous IGEM plate) Oligo: TM
| - | - | - |
Verification on gel :
ok | - | - | - |
Purification on gel :
ok | - | - | -
|
Digestion:
Ter E/X mRFP E/S | - | - | - |
Digestion checking:
ok | - | - | -
|
Ligation:
mRFP E/S Ter E/X in Ter vector | - | - | - |
Colony PCR:
ok | - | - | - |
Miniprep:
ok | - | - | - |
Sequencing :
ok |
- |
- |
- |
Stock glycerol:
- | - | - | - |
Experiments ran :
Column 1 | Column 2 | Column 3 | Column 4 |
PCR :
pFec matrix: K12 DNA Oligo: TM FecI matrix: K12 DNA Oligo: TM FecR 1-85 matrix: K12 DNA Oligo: TM mRFP matrix: PSB1A3 (previous IGEM plate) Oligo: TM
| - | - | - |
Verification on gel :
ok |
- |
- |
- |
Purification on gel :
ok |
- |
- |
-
|
Digestion:
Ter E/X mRFP E/S | - | - | - |
Verification digestion:
ok |
- |
- |
-
|
Ligation:
mRFP E/S Ter E/X in Ter vector | - | - | - |
Colony PCR:
ok | -
- | -
- |
- |
Miniprep:
ok |
- |
- |
- |
Sequencing :
ok |
- |
- |
- |
Stock glycerol:
- |
- |
- |
- |
Experiments ran :
Column 1 | Column 2 | Column 3 | Column 4 |
PCR :
FecA matrix: K12 pBAD: OmpAs: pINR2 | '- | - | - |
Verification on gel :
ok |
- |
- | -
- |
Purification on gel :
ok | -
- | -
- | -
-
|
Digestion:
pBAD E/S | Digestion:
none | - | - |
Digestion checking
ok | Digestion checking
none |
- |
-
|
Ligation:
none | Ligation:
none | - | - |
Colony PCR :
none | Colony PCR :
none |
- |
- |
Miniprep
none | Miniprep
none |
- |
- |
Sequencing
none | Sequencing
none |
- |
- |
Stock glycerol:
none | Stock glycerol:
none | - |
- |